These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1595221)

  • 1. [Manifestations and early course of type I diabetes mellitus--a decisive period from the viewpoint of controlling the further development of the disease].
    Vondra K; Merhaut T; Voborská M; Zamrazil V
    Vnitr Lek; 1992 Mar; 38(3):281-8. PubMed ID: 1595221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Latent autoimmune diabetes in adults: an update].
    Zhou ZG; Li X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):630-4. PubMed ID: 14650175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction and diagnosis of type 1 diabetes using beta-cell autoantibodies.
    Batstra MR; Aanstoot HJ; Herbrink P
    Clin Lab; 2001; 47(9-10):497-507. PubMed ID: 11596913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical remission in type 1 diabetes mellitus].
    Krokowski M; Zmysłowska A; Bodalski J
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 1999; 5(2):103-7. PubMed ID: 12818093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Amylin as an additional possible pathogenic factor in NIDDM and the insulin resistance syndrome].
    Hrnciar J
    Vnitr Lek; 1996 Aug; 42(8):557-60. PubMed ID: 8967027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New findings on the pathogenesis of diabetes mellitus].
    Keller U
    Schweiz Med Wochenschr; 1986 Jan; 116(3):66-71. PubMed ID: 3511524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors predicting remission in type I diabetes.
    Pelkonen R; Aro A
    Ann Clin Res; 1984; 16(2):94-7. PubMed ID: 6380392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical heterogeneity of childhood diabetes in Baranya county].
    Makovi H; Soltész G; Hermann R
    Orv Hetil; 2002 Nov; 143(44):2489-92. PubMed ID: 12674804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulation for the prevention of SPIDDM and LADA.
    Pozzilli P; Guglielmi C
    Ann N Y Acad Sci; 2006 Oct; 1079():90-8. PubMed ID: 17130536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific therapeutic attempts in experimental and clinical type-I diabetes.
    Federlin K; Becker F
    Klin Wochenschr; 1990; 68 Suppl 21():38-43. PubMed ID: 2198389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cell mediated therapy for immunoregulation of type 1 diabetes mellitus.
    Phillips BE; Giannoukakis N; Trucco M
    Pediatr Endocrinol Rev; 2008 Jun; 5(4):873-9. PubMed ID: 18552749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of the onset and progression of peripheral neuropathy and hypertension in NIDDM].
    Jarmuzewska EA; Ghidoni A
    Minerva Med; 2000; 91(1-2):1-15. PubMed ID: 10858728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Insulitis--new findings on the role of genetic and external factors].
    Vondra K; Stolba P; Zamrazil V
    Cas Lek Cesk; 1991 Nov; 130(18-19):529-33. PubMed ID: 1764714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Will type I diabetes mellitus be treated with immunosuppressive drugs in the future?].
    Diem P
    Ther Umsch; 1993 Feb; 50(2):114-8. PubMed ID: 8456415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Etiology and pathogenesis of type I diabetes].
    Ziegler AG
    Z Gesamte Inn Med; 1993 Mar; 48(3):100-7. PubMed ID: 8475631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Principles of immunotherapy in insulin-dependent diabetes mellitus].
    Bretzel RG
    Wien Klin Wochenschr; 1988 Jun; 100(13):435-42. PubMed ID: 3043913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autoimmunity and glutamate decarboxylase antibodies in the pathogenesis of type I diabetes mellitus in experimental and clinical practice].
    Kucera P; Andĕl M; Treslová L
    Vnitr Lek; 1996 May; 42(5):359-67. PubMed ID: 8768297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autoimmunity and insulin-dependent diabetes mellitus. Experimental data and therapeutic prospects].
    Thivolet C; Khallouf E
    Pediatrie; 1989; 44(4):247-57. PubMed ID: 2677968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe clinical onset of diabetes and increased prevalence of other autoimmune diseases in children with coeliac disease diagnosed before diabetes mellitus.
    Valerio G; Maiuri L; Troncone R; Buono P; Lombardi F; Palmieri R; Franzese A
    Diabetologia; 2002 Dec; 45(12):1719-22. PubMed ID: 12488963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.